HQH
abrdn Healthcare InvestorsHQH
HQH
About: abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
73% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 11
15% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 33
6% more funds holding
Funds holding: 109 [Q2] → 115 (+6) [Q3]
6.27% less ownership
Funds ownership: 32.38% [Q2] → 26.11% (-6.27%) [Q3]
14% less capital invested
Capital invested by funds: $273M [Q2] → $234M (-$39M) [Q3]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for HQH.
Financial journalist opinion
Based on 4 articles about HQH published over the past 30 days
Neutral
Seeking Alpha
5 days ago
Aberdeen Or 'abrdn' - Either Way The Coverage Looks A Bit Thin
Closed-end funds offer unique advantages, like buying at discounts and leveraging with institutionally priced debt, making them ideal income-generating vehicles. Cash distributions are key contributors to total return, but it is essential to be sure they are actually covered by fund earnings. Some investors overly prioritize distribution yields, neglecting the importance of considering total return as a whole.
Positive
Seeking Alpha
2 weeks ago
Don't Miss The Dividend Train, Yields Up To 15%
For over 400 years, dividends have been a steady form of capital from the markets to your account. Dividends can generate dependable and powerful paychecks. We discuss two big yields from dependable sectors.
Negative
Seeking Alpha
2 weeks ago
HQH: Not For Income Investors
I maintain a sell rating on the abrdn Healthcare Investors fund due to its incongruence with income investing and managed distribution plans. HQH has underperformed the Nasdaq Biotechnology Index and iShares Biotechnology ETF, highlighting its inability to generate alpha versus more tax-efficient alternatives. The fund's high yield is unsustainable, relying on capital gains and potentially forcing premature sales, which is unsuitable for income-oriented investors.
Positive
Forbes
4 weeks ago
My Top Retirement Strategy For 14% Dividends In 2025
Not many people know this, but if you really want to diversify—deftly balancing and rebalancing to maximize (and protect) your gains, you need to invest in closed-end funds (CEFs).
Neutral
Seeking Alpha
1 month ago
11 Closed-End Fund Buys In The Month Of November 2024
This month, I've added to 11 different positions, but most of these were related to repurchases after the BlackRock tender offers. While I added to 11 different positions, these were all positions I had already held previously, so there were no new positions this month. In fact, I sold out of a fund to consolidate my holdings and reduce the number of funds held, as I did last month as well.
Positive
Seeking Alpha
1 month ago
2 Cyber Monday Picks I Am Buying Hand Over Fist
Buy income streams on sale, and collect your rewards for decades to come. I collect income from the market, not just cash from selling positions. Let the market fund your life; don't just dismantle your life savings.
Positive
Seeking Alpha
2 months ago
HQH: Declines Bring Potential Opportunity
HQH has seen pressure recently due to regulatory uncertainty; while the closed-end funds discount has actually narrowed, it could be an interesting place to put some capital to work. The fund's 12% managed distribution policy has attracted interest from yield investors, though a quarterly pay may be less appealing. HQH's portfolio is tilted toward a heavier weight in biotech, with top holdings like Gilead Sciences showing resilience while others like Regeneron and Eli Lilly have struggled.
Neutral
Seeking Alpha
2 months ago
Worried About A Recession? Income Solutions With Yields Up To 13%
Time in the market trumps timing the market, but the timing of your retirement matters. In retirement, you need a portfolio capable of providing reliable income and mitigating sequence of return risk. We discuss two robust picks geared to provide steady income in retirement.
Positive
Seeking Alpha
4 months ago
HQH: High Yielding Exposure To Biotech With Positive Outlook
abrdn Healthcare Investors operates as a closed end fund that aims to provide total returns comprised of high current income. HQH offers a high-yielding dividend rate of 12.7% and distributions are paid out on a monthly basis. The fund's focus on biotech holdings makes it vulnerable to interest rate changes but also positions it for potential growth with lower rates.
Positive
Seeking Alpha
5 months ago
Retire With Dividends: 2 Picks With Yields Up To 12%
The prospects of a failed retirement are only heightened by a recession at the start of your retirement. Change the fuel behind your retirement finances with dividends vs. capital withdrawals. Unlock up to 12% yields with these income opportunities.
Charts implemented using Lightweight Charts™